Importer of Controlled Substances Application: CATALENT CTS, LLC, 34551 [2014-14123]

Download as PDF Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices service list), and a certificate of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service. Issued: June 12, 2014. Lisa R. Barton, Secretary to the Commission. Authority: This review is being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.62 of the Commission’s rules. BILLING CODE 7020–02–P [FR Doc. 2014–14146 Filed 6–16–14; 8:45 am] DEPARTMENT OF JUSTICE By order of the Commission. Issued: June 12, 2014. Lisa R. Barton, Secretary to the Commission. Drug Enforcement Administration [Docket No. DEA–392] [FR Doc. 2014–14148 Filed 6–16–14; 8:45 am] Importer of Controlled Substances Application: CATALENT CTS, LLC BILLING CODE 7020–02–P ACTION: INTERNATIONAL TRADE COMMISSION Silicon Metal From Russia Determination On the basis of the record 1 developed in the subject five-year review, the United States International Trade Commission (Commission) determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. § 1675(c)), that revocation of the antidumping duty order would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.2 tkelley on DSK3SPTVN1PROD with NOTICES Background The Commission instituted this review on June 3, 2013 (78 FR 33064) and determined on September 6, 2013 that it would conduct a full review (78 FR 61384, October 3, 2013). Notice of the scheduling of the Commission’s review and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register on December 19, 2013 (78 FR 76856). The hearing was cancelled, on April 7, 2014 (79 FR 19921, April 10, 2014). The Commission completed and filed its determination in this review on June 11, 2014. The views of the Commission are contained in USITC Publication 4471 (June 2014), entitled Silicon Metal from Russia: Investigation No. 731–TA– 991 (Second Review). By order of the Commission. 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR § 207.2(f)). 2 Commissioner Rhonda K. Schmidtlein did not participate in the vote. 16:43 Jun 16, 2014 Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before July 17, 2014. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before July 17, 2014. DATES: [Investigation No. 731–TA–991 (Second Review)] VerDate Mar<15>2010 Notice of application. Jkt 232001 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESS: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to sec. 7(g) of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.34(a), this is notice that on May 7, 2014, Catalent CTS, LLC, 10245 Hickman Mills Drive, Kansas City, Missouri 64137, applied to be registered as an importer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Marihuana (7360) ......................... Poppy Straw Concentrate (9670) PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Schedule I II 34551 The company plans to import a finished pharmaceutical product containing cannabis extracts in dosage form for a clinical trial study. In reference to drug code 7360, the company plans to import a synthetic cannabidiol. This compound is listed under drug code 7360. No other activity for this drug code is authorized for this registration. In addition, the company plans to import an ointment for the treatment of wounds which contain trace amounts of the controlled substances normally found in poppy straw concentrate for packaging and labeling to be used in clinical trials. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007). Dated: June 10, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2014–14123 Filed 6–16–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: ALKERMES GAINESVILLE LLC ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before July 17, 2014. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before July 17, 2014. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and SUPPLEMENTARY INFORMATION: E:\FR\FM\17JNN1.SGM 17JNN1

Agencies

[Federal Register Volume 79, Number 116 (Tuesday, June 17, 2014)]
[Notices]
[Page 34551]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14123]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: CATALENT CTS, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.34(a) on or before July 17, 2014. Such persons may also file a 
written request for a hearing on the application pursuant to 21 CFR 
1301.43 on or before July 17, 2014.

ADDRESS: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, and dispensers of controlled substances 
(other than final orders in connection with suspension, denial, or 
revocation of registration) has been redelegated to the Deputy 
Assistant Administrator of the DEA Office of Diversion Control 
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR 
pt. 0, subpt. R, App.
    In accordance with 21 CFR 1301.34(a), this is notice that on May 7, 
2014, Catalent CTS, LLC, 10245 Hickman Mills Drive, Kansas City, 
Missouri 64137, applied to be registered as an importer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import a finished pharmaceutical product 
containing cannabis extracts in dosage form for a clinical trial study.
    In reference to drug code 7360, the company plans to import a 
synthetic cannabidiol. This compound is listed under drug code 7360. No 
other activity for this drug code is authorized for this registration.
    In addition, the company plans to import an ointment for the 
treatment of wounds which contain trace amounts of the controlled 
substances normally found in poppy straw concentrate for packaging and 
labeling to be used in clinical trials.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (January 25, 
2007).

    Dated: June 10, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-14123 Filed 6-16-14; 8:45 am]
BILLING CODE 4410-09-P